Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study

Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study

<p>Abstract</p> <p>Background</p> <p>Currently there is no effective treatment available to retard cyst growth and to prevent the progression to end-stage renal failure in patients with autosomal dominant polycystic kidney disease (ADPKD). Evidence has recently been obt...

Full description

Bibliographic Details
Main Authors:	Wüthrich Rudolf P, Struker Marian, Poster Diane, Kistler Andreas D, Serra Andreas L, Weishaupt Dominik, Tschirch Frank
Format:	Article
Language:	English
Published:	BMC 2007-09-01
Series:	BMC Nephrology
Online Access:	http://www.biomedcentral.com/1471-2369/8/13

Similar Items

Low-dose oral sirolimus and the risk of menstrual-cycle disturbances and ovarian cysts: analysis of the randomized controlled SUISSE ADPKD trial.
by: Matthias Braun, et al.
Published: (2012-01-01)

Echocardiographic Abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients
by: Mariana Becker Pfeferman, et al.
Published: (2022-10-01)

Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study.
by: Andreas D Kistler, et al.
Published: (2013-01-01)

A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model
by: Phil McEwan, et al.
Published: (2018-02-01)

Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD)
by: Ilnaz Rahimmanesh, et al.
Published: (2020-01-01)

AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) IN A LARGE IRANIAN FAMILY
by: D.D. Farhud, et al.
Published: (1999-06-01)

Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
by: Anna A. Kiseleva, et al.
Published: (2020-02-01)

Correction: Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study.
by: Andreas D. Kistler, et al.
Published: (2013-01-01)

Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
by: Raina R, et al.
Published: (2022-09-01)

Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) During Pregnancy: Risks and Challenges
by: McBride L, et al.
Published: (2020-05-01)

Bone health in autosomal dominant polycystic kidney disease (ADPKD) patients after kidney transplantation
by: Dalia Zubidat, et al.
Published: (2023-06-01)

Association of Vitamin D Levels With Kidney Volume in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
by: Larissa Collis Vendramini, et al.
Published: (2019-05-01)

Opposing effects of inhibitors of Aurora-A and EGFR in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
by: Anna S Nikonova, et al.
Published: (2015-10-01)

Urinary biomarkers at early ADPKD disease stage.
by: Katja Petzold, et al.
Published: (2015-01-01)

Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD)
by: Akinari Sekine, et al.
Published: (2022-11-01)

Characteristics of the ruptured intracranial cerebral aneurysms in patients with autosomal dominant polycystic kidney disease (ADPKD) and review of literature
by: Katsuya Masui, et al.
Published: (2020-12-01)

Total and Extracellular Vesicle cAMP Contents in Urine Are Associated with Autosomal Dominant Polycystic Kidney Disease (ADPKD) Progression
by: María Lucía Rosenberg, et al.
Published: (2023-08-01)

Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD)
by: Jan Dudley, et al.
Published: (2019-04-01)

Incoercible Vomiting in a Polycystic (ADPKD) Patient on Peritoneal Dialysis
by: Victor Burguera Vion, et al.
Published: (2021-11-01)

Kidney transplantation with concomitant simple nephrectomy by thoracoabdominal approach for patients with huge autosomal dominant polycystic kidney disease (ADPKD): A case report
by: Yasutoshi Yamada, et al.
Published: (2019-09-01)

Modified Supine Hand Assisted Laparoscopic (HAL) bilateral nephrectomy for Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Step-by-Step technique
by: Ee Jean Lim, et al.
Published: (2021-09-01)

High Resolution Ultrasonography for Assessment of Renal Cysts in the PCK Rat Model of Autosomal Recessive Polycystic Kidney Disease
by: Sarika Kapoor, et al.
Published: (2016-03-01)

Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing
by: Othman R. Alzahrani, et al.
Published: (2022-11-01)

Idiosyncratic hepatic toxicity in autosomal dominant polycystic kidney disease (ADPKD) patient in combined treatment with tolvaptan and amoxicillin/clavulanic acid: a case report
by: Angela Maria Pellegrino, et al.
Published: (2019-11-01)

Early Urinary Biomarkers in Pediatric Autosomal Dominant Polycystic Kidney Disease (ADPKD): No Evidence in the Interest of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL)
by: Marianthi Tsingos, et al.
Published: (2019-03-01)

Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model
by: Hayley Bennett, et al.
Published: (2019-04-01)

Case Report: an unusual cause of cyst infection in adult polycystic kidney disease (ADPKD)
by: A. Sunavala, et al.
Published: (2017-12-01)

Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease.
by: Dongping Chen, et al.
Published: (2014-01-01)

Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe
by: Dominique Joly, et al.
Published: (2020-07-01)

Treatment of autosomal recessive and autosomal dominant polycystic kidney disease
by: E. F. Andreeva, et al.
Published: (2019-05-01)

Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease.
by: Kanishka Sharma, et al.
Published: (2017-01-01)

RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study
by: Jenq-Wen Huang, et al.
Published: (2020-02-01)

AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE
by: Anja Fon Gabršček, et al.
Published: (2022-03-01)

High Magnesium and Sirolimus on Rabbit Vascular Cells—An In Vitro Proof of Concept
by: Giorgia Fedele, et al.
Published: (2021-04-01)

Polycystins, ADPKD, and Cardiovascular Disease
by: Ivana Y. Kuo, et al.
Published: (2020-04-01)

Simultaneous laparoscopic nephrectomy in ADPKD
by: Baishya Ramen, et al.
Published: (2010-01-01)

Autosomal dominant polycystic kidney disease in Colombia
by: Jessica T. Camargo, et al.
Published: (2023-07-01)

Autophagy and Autosomal Dominant Polycystic Kidney Disease
by: Özgür Akın Oto, et al.
Published: (2023-01-01)

Autosomal dominant polycystic kidney disease in children
by: Kiran Chandra Patro, et al.
Published: (2016-01-01)

Hypertension in Autosomal Dominant Polycystic Kidney Disease
by: Al-Khader Abdullah
Published: (1999-01-01)